The polyamino‐isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi‐target inhibitors against the ESKAPEE bacterium Enterobacter cloacae

Abstract Gram‐negative bacteria are particularly prone to developing antimicrobial resistance (AMR), as evidenced by the WHO's ESKAPEE list of high‐priority pathogens. One strategy that has increased is the use of antibiotic enhancers, which can re‐empower abandoned or poorly active antibiotics agai...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Emma Forest, Jordan Lehoux, Alexandre Guy, Thierry Durand, Stéphane Audebert, Luc Camoin, Christopher D. Spilling, Céline Crauste, Stéphane Canaan, Jean Michel Brunel, Jean‐Michel Bolla, Jean‐François Cavalier
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-06-01
Edice:	mLife
Témata:	activity based‐protein profiling antibiotic resistance Cyclipostins and Cyclophostin analogs drug enhancers oxadiazolone derivatives
On-line přístup:	https://doi.org/10.1002/mlf2.70014
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!